S&P 500 (SPY) $729.46 -1.54%Nasdaq 100 (QQQ) $661.73 -2.04%Dow Jones (DIA) $515.41 -2.18%Russell 2000 (IWM) $288.57 -1.64%Gold (GLD) $371.08 +0.46%10Y Bond (TLT) $82.85 -1.65% S&P 500 (SPY) $729.46 -1.54%Nasdaq 100 (QQQ) $661.73 -2.04%Dow Jones (DIA) $515.41 -2.18%Russell 2000 (IWM) $288.57 -1.64%Gold (GLD) $371.08 +0.46%10Y Bond (TLT) $82.85 -1.65%
Earnings July 30, 2026 at 6:01 AM

Align Technology Inc Q3 2026 Earnings: Miss on Both Revenue and EPS

Align Technology Inc (ALGN) reported third-quarter 2026 earnings that fell short of Wall Street expectations on both the top and bottom lines. The clear aligner and digital orthodontics company posted earnings per share of $2.64 versus the consensus estimate of $2.66, representing a -0.87% surprise. Revenue came in at $1.056 billion, missing the $1.073 billion estimate by -1.57%.

Align Technology is the maker of Invisalign clear aligners and iTero intraoral scanners, serving orthodontists, general practitioners, and consumers through its direct-to-consumer SmileDirectClub acquisition. The company operates primarily through two segments: Clear Aligner (Invisalign) and Systems and Services (iTero scanners and digital services).

Earnings Performance Falls Short of Expectations

The $2.64 EPS represents a modest miss against analyst projections, with the -0.87% surprise indicating relatively tight forecasting accuracy despite the shortfall. This EPS figure reflects the company’s continued profitability in the competitive orthodontics market, though execution fell slightly below investor expectations for the quarter.

Revenue of $1.056 billion, while missing estimates, still represents substantial scale for the digital orthodontics leader. The -1.57% revenue surprise suggests softer demand or execution challenges compared to analyst models heading into the quarter.

Quarterly Revenue Trends and Market Position

The $1.056 billion in quarterly revenue demonstrates Align’s position as the dominant player in the clear aligner market, competing against traditional braces and newer entrants like Candid and Byte. The company’s revenue mix typically skews heavily toward its Invisalign clear aligner business, which generates the majority of total sales through case shipments to orthodontists and general practitioners globally.

Align’s iTero scanner business provides a complementary revenue stream through equipment sales and recurring digital services, supporting the company’s integrated approach to digital orthodontics. The scanner business also creates switching costs for practitioners and generates higher-margin recurring revenue through software subscriptions and services.

Market Dynamics and Competitive Landscape

The slight revenue miss comes amid ongoing competition in the clear aligner space, with traditional orthodontic companies and direct-to-consumer startups vying for market share. Align has historically maintained pricing power through its first-mover advantage and extensive patent portfolio, though increased competition has pressured growth rates in recent quarters.

International expansion remains a key growth driver for Align, particularly in emerging markets where orthodontic penetration rates remain low compared to developed markets. The company’s direct-to-consumer initiatives through SmileDirectClub also represent an effort to capture price-sensitive segments of the market.

Investor Implications and Forward Outlook

The dual miss on earnings and revenue may prompt questions about demand trends in the orthodontics market and Align’s execution against its growth initiatives. Investors will likely focus on management commentary regarding case volume trends, average selling prices, and the competitive environment during the earnings call.

The performance also raises questions about the sustainability of Align’s premium valuation relative to the broader medical device sector, particularly if growth rates continue to moderate. Market participants will be watching for updated guidance on full-year 2026 expectations and commentary on 2027 outlook trends.

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with financial advisors before making investment decisions.